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Abstract
Thromboembolic disease is a leading cause of morbidity and mortality worldwide. In the last several years there have been a
number of studies attempting to identify mechanisms that stop thrombus growth. This paper identifies a novel mechanism
related to formation of a fibrin cap. In particular, protein transport through a fibrin network, an important component of a
thrombus, was studied by integrating experiments with model simulations. The network permeability and the protein
diffusivity were shown to be important factors determining the transport of proteins through the fibrin network. Our
previous in vivo studies in mice have shown that stabilized non-occluding thrombi are covered by a fibrin network (‘fibrin
cap’). Model simulations, calibrated using experiments in microfluidic devices and accounting for the permeable structure of
the fibrin cap, demonstrated that thrombin generated inside the thrombus was washed downstream through the fibrin
network, thus limiting exposure of platelets on the thrombus surface to thrombin. Moreover, by restricting the approach of
resting platelets in the flowing blood to the thrombus core, the fibrin cap impaired platelets from reaching regions of high
thrombin concentration necessary for platelet activation and limited thrombus growth. The formation of a fibrin cap
prevents small thrombi that frequently develop in the absence of major injury in the 60000 km of vessels in the body from
developing into life threatening events.
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Introduction
Damage or inflammation to the blood vessel wall initiates the
development of intravascular clots (thrombi). Uncontrolled growth
of thrombi can result in occlusion of the blood vessel, starving
tissues in the flow field of nutrients and oxygen. Furthermore, clot
fragments washed away from the thrombus (emboli) may lodge in
the vasculature of the lungs and brain causing life threatening
conditions such as pulmonary embolism and ischemic stroke.
Thromboembolic disease is a major biomedical problem with
900,000 cases per year in the USA leading to 300,000 deaths [1].
We have reported [2–5] that following laser-induced injury to a
few cells lining the vessel wall small non-occlusive thrombi initially
grow rapidly by accumulating platelets. After several minutes,
growth ceases and the thrombi stabilize. The cessation of growth
occurs as the surface composition of the developing thrombus
changes. While actively growing during the first few minutes
following injury the surface is composed primarily of platelets. As
the thrombus stabilizes the surface composition changes to one
composed primarily of a fibrin network containing cellular and
platelet clusters (Figure 1).
We previously developed multi-scale models of clot formation
taking into account all main components including hemodynam-
ics, molecular signaling leading to platelet activation and
coagulation biochemical reactions taking place in blood and on
surfaces of platelets [4,6]. A combination of experimental
approaches, image analysis and multi-scale modeling was used
for formulating a novel biological hypothesis of a fibrin cap being
capable of stopping blood clot growth by interfering with the
transport of thrombin to the thrombus surface. Thrombin is a
potent platelet activator and is required for fibrin generation
[4,7,8]. By interfering with thrombin transport to the thrombus
surface, we hypothesize the fibrin cap can limit further growth.
Because thrombin is primarily generated by coagulation
reactions concentrated on the surface of activated platelets in the
thrombus [9], it is important to study the movement of thrombin
through the fibrin network to determine if the network limits the
distribution of thrombin to affect thrombus growth. Conceivably,
the fibrin network forms a diffusion and permeability barrier and
prevents the transport of thrombin to the thrombus surface.
This paper examines this hypothesis by studying in detail
protein advection and diffusion to describe thrombin transport
through fibrin networks (fibrin cap). It integrates computational
and experimental analysis to show how the formation of a fibrin
network limits thrombus growth. Network permeability and
protein diffusion are the important factors determining the
transport of proteins through the fibrin network of thrombi. We
report on the experimental measurements of these factors and the
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development of a thrombus hemodynamics model incorporating
them. We show that networks formed under physiological
concentrations of fibrinogen and thrombin do not appreciably
affect the diffusion of thrombin indicating the fibrin network
does not provide a diffusion barrier. However, it is demonstrat-
ed that in permeable fibrin network, thrombin generated by
platelets is rapidly washed downstream by advection. Only a
thin band upstream and above the source of thrombin maintains
an appreciable thrombin concentration, similar to the distribu-
tion expected in the absence of a fibrin network. However, the
pore size in a newly formed sparse network is small enough to
exclude resting platelets in flowing blood from approaching the
thrombus core. The resting platelets in flowing blood contacting
the thrombus therefore do not reach regions with sufficiently
high thrombin concentration necessary for their activation and
stable incorporation into the developing thrombus. Thus, the
development of a sparse, permeable fibrin network on the
thrombus surface may provide a mechanism to limit continued
growth of small thrombi. The network does not provide a
transport barrier for thrombin but rather a shield blocking
resting platelets from approaching sites of thrombin generation.
Our results identify a novel mechanism and reinforces the
concept that the spatial separation of sites of factor activation
and factor activity are important to understanding thrombo-
genesis. The suggested mechanism may prevent small thrombi,
which frequently form as a result of activation or damage of a
few endothelial cells, from growing into symptomatic occlusive
clots.
Results/Discussion
Since thrombin is critical for continued thrombus growth, we
developed a thrombus hemodynamics model to compute the
thrombin concentration at different positions in the thrombus.
The model assumes thrombin is generated on the surface of
activated platelets in the thrombus core and is transported through
the fibrin network that surrounds the core both by advective flow
of fluid permeating through the fibrin network and by diffusion
through the fibrin gel. To calibrate the model, we experimentally
determined fibrin clot permeability and thrombin diffusion rates
through a fibrin network. Permeability was determined by
perfusing liquid through fibrin gels formed with a physiological
range of fibrin concentrations (0.5 to 4.0 mg/ml). Protein diffusion
rates were determined using Fluorescence Recovery after Photo-
bleaching (FRAP) [10] protocols (Figure 2A). In addition, we also
examined the diffusion rates of larger molecules, Fab IgG
(MW=50 kDa), in fibrin networks to assess the effect of the
protein size on its diffusion. The experimentally determined
measurements of permeability, protein diffusivity and the fibrin
network density were then used for predictive analysis in the
thrombus hemodynamic model.
Protein Size Measurements
Before quantifying the transport of proteins in fibrin networks,
protein diameter distributions were measured using Dynamic
Light Scattering (DLS) (Figure 2B). The mean hydrodynamic
diameter vdsw of thrombin and Fab IgG solutes were found to
be 4.1 nm and 11.2 nm, respectively. These are in a remarkable
agreement with x-ray diffraction results, reporting the size of
packing orthorhombic cells to be (4.5 nm|4.5 nm|5.0 nm) and
Figure 1. Composition of developing thrombi obtained from vertical stacks of images collected by multiphoton microscopy of laser
induced injuries in mesenteric veins of a mice. 3D image reconstruction of a late stage thrombus is shown in (a) (luminal view) and (b) cross
section in a vertical plane (wall is on the left, lumen is on the right). Regions composed mostly of platelets are red, mostly of fibrin - green, composed
of platelets and fibrin -yellow; and regions excluding plasma, fibrin and platelets (other material, cells) - black. (c) Shows evolution of the thrombus
composition as it stabilizes. Stabilization is associated with decreasing amounts of platelets and increasing amounts of fibrin on the surface.
doi:10.1371/journal.pcbi.1003095.g001
Author Summary
To restrict the loss of blood following rupture of blood
vessels, the human body rapidly forms a clot consisting
mainly of platelets and fibrin. However, to prevent
formation of a pathological clot within vessels (thrombus)
as a result of vessel damage or dysfunction, the response
must be regulated, and clot formation must be limited.
Our previous studies demonstrated that as a laser-induced
thrombus stabilized in mice, the ratio of fibrin to platelets
at the thrombus surface increased significantly. Stabilized
non-occluding thrombi were observed to be covered by a
fibrin network (‘fibrin cap’). In the present work the role of
the fibrin network in protein transport is examined by
integrating experiments in microfluidic devices with the
hemodynamic thrombus model. The study reveals perme-
ability of the fibrin network and protein diffusivity to be
important factors determining the transport of blood
proteins inside the thrombus. It is shown that the fibrin
network does not dramatically limit the diffusion of
thrombin but impairs flowing platelets in blood from
reaching regions of high thrombin concentration thus,
reducing the probability they are activated and stably
integrated into the thrombus. This novel, counter-intuitive
mechanism suggests that a fibrin network formed at early
stages of thrombus initiation can prevent normally
asymptomatic thrombi from developing into pathological
clots.
Protein Transport through Fibrin Networks
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(8.06 nm|7.22 nm|18.76 nm) for thrombin [11–13] and IgG
Fab complexes [14], respectively.
Fibrin Network Permeation
Permeability of the fibrin networks was quantified from Darcy’s
equation using liquid flow rate and pressure gradient measure-
ments across the fibrin networks. Our measurements showed a
substantial decrease of the fibrin network permeability (Darcy’s
constant) by three orders of magnitude, as the fibrinogen
concentration increased from 0.2 mg/mL to 4 mg/mL. A power
law fit was used to obtain an explicit relationship between the
permeability, k, and the fibrin volume fraction, w. This gave
k~3:10{16(w{w0)
{1:8, with w0~0:0028 (Figure 3A). w0 does not
equal zero because it was difficult to collect consistent data for clots
prepared at fibrinogen concentrations lower than 1 mg/mL.
Under slight hydrostatic pressure the clot fibers deformed, broke
near wall regions, and bundled together, severely disrupting the
network structure. Meanwhile, clots prepared with fibrinogen
concentrations higher than 1 mg/mL were stable to imposed
pressure. The measured permeability k was in the range from 1 to
1000 mm2. This means that the ratio of rs=
ffiffiffi
k
p
, where rs~ds=2 is
the protein hydrodynamic radius, is much smaller than 1 and
therefore, the effect of hydrodynamic hinderance on diffusion
(Equation (2) in Text S2) can be neglected.
From the relation obtained by Diamond and Anand [15,16],
k~4=70r2f w
{1:5(1z52w1:5){1 ð1Þ
the fiber radius, rf , was found using the measured k and w values.
The calculated fiber radii ranged from 150 nm to 500 nm
(Figure 3B), which is in good agreement with the fiber thicknesses
evaluated directly from confocal images and with previously
reported values of hydrated fiber bundles [16,17] of coarse gels.
The average fiber radius was found to decrease from approx-
imately 450 nm to 200 nm when fibrinogen concentration
increased from 1 mg/mL to 4 mg/mL.
Protein Diffusivity in Fibrin Networks
The values of the diffusion coefficients and mobile fractions of
thrombin and Fab IgG were obtained by fitting experimental data
obtained by FRAP experiments (Text S1) using Levenberg-
Marquardt curve-fitting [18]. The resulting diffusion coefficients
are plotted as a function of fibrinogen concentration in Figure 4.
For comparison, data reported by Stewart et al. 1988 [19] for BSA
molecules and by Spero et al. 2010 [20] for 228 nm and 526 nm
diameter PEG-coated particles are also shown. The diffusion
coefficient of thrombin and Fab IgG in solution in the absence of
fibrinogen were found to be 110+2.6 mm2/s and 40+0.9 mm2=s,
respectively. By determining the corresponding molecular diam-
eters, one can show that these are in a very good agreement with
our DLS measurements. Indeed, from the Stokes-Einstein relation
D~kBT=(6pgrs), it follows that D
aT
0 =D
IgG
0 *d
IgG
s =d
aT
s . Accord-
ing to our FRAP measurements, the ratio of the diffusion
coefficients of thrombin to that of IgG in liquid is
Figure 2. A: FRAP microscopy of fluorescently labeled Fab fragments of IgG. For a typical FRAP experiment performed on a fibrin network,
the regions of interest (ROIs, radius of 27 mm) before, immediately after photobleaching, and after 98 s are shown (green circle). Normalized
fluorescence recovery for the corresponding ROIs and their fits according to a model (Equation (7), Text S1) are shown by symbols and a line,
respectively. Fluorescence intensity values before (Ii) and after (I0) photobleaching, and at the end of the experiment (I‘), are shown. For each
sample, FRAP measurements were repeated 3 times in 8 different locations over the sample and the arithmetic mean of the intensity curves was
taken. B: Hydrodynamic diameter measurements by dynamic light scattering: circles denote a-thrombin and squares denote Fab IgG.
doi:10.1371/journal.pcbi.1003095.g002
Figure 3. A: Permeability as a function of fiber volume fraction
in fibrin gels. Circles correspond to data collected for clots in plastic
tubes and squares show the data for clots in glass capillaries. Line is a
fit: 3:10{16(w{w0)
{1:8 , w0~0:0028. B: Fiber radius versus fibrinogen
concentration determined from permeability measurements and
Equation (1) (circles) and from confocal microscopy images (squares).
doi:10.1371/journal.pcbi.1003095.g003
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DaT0 =D
IgG
0 =2.86. Taking d
aT
s *4.1 nm, yields the hydrodynamic
diameter for IgG dIgGs *11.2 nm, which is in agreement with the
value given by DLS (Figure 2B).
There are no noticeable changes in the diffusion coefficient of
thrombin and Fab IgG up to a fibrinogen concentration of 2 mg/
mL and 0.4 mg/mL, respectively, indicating no diffusion retar-
dation. However, the increase of fibrinogen concentration to
4 mg/mL reduced diffusivity of Fab IgG by 22% and diffusivity of
thrombin by 13%, indicating that fibrin network structure impedes
the molecular diffusion due to smaller gel pore size. Pore size
between fibers was estimated from microscope images to vary from
10 mm at 0.4 mg/mL of fibrinogen to less than the microscope
resolution of 0.2 mm at 4 mg/mL of fibrinogen. These estimates
did not consider pores between fibrils whose dimensions were
beyond the microscope resolution limit. Our results also showed
that the noticeable changes of thrombin diffusivity occurred when
fibrinogen exceeded 2 mg/mL. This correlates with measure-
ments of thrombin adsorption [21], which demonstrated the
thrombin absorption increase between 2 mg/mL and 4 mg/mL of
fibrinogen.
Comparison of the diffusion coefficients obtained from FRAP
measurements with diffusion models (Figure 4) shows that the
extended Ogston’s model [22] fit the data well, whereas the
Johnson model given by Equation (3) in Text S2, overestimates
protein diffusion. Here, the diffusivity is plotted as a function offfiffiffi
a
p
, where a is calculated according to Equation (3). The model
fitting parameters are given in Table 1.
Protein Mobile Fraction. From our FRAP experiments we
found that a small fraction of probe molecules (1% to 5%) were
immobile (Figures 5A, 5B). This suggests the importance of
considering probe-fiber interaction including molecular binding
and probe trapping in fibrin fiber nano-pores to understand
protein transport through fibrin networks. Indeed, because fibrin
polymerization occurred while probe molecules were present in
the fibrinogen solution, the polymerized fibers might incorporate
probe molecules. These molecules can be introduced in fibers as a
solute phase, in the case of Fab IgG, or as both a solute phase and
as molecules specifically bound to fibrin, in the case of thrombin.
The SAXS experiments [23] revealed that depending on
fibrinogen concentration, the solute phase in fibers can reach
80% with an average of 50–60%. Although gels in these
experiments did not contain probe molecules, in our study, we
anticipate a certain fraction of the probe proteins (non-interacting
Fab IgG and possibly interacting thrombin) to be present as a
solute in the fiber nano-pores. We do not expect binding of Fab
IgG to the fibrin surface. However, we presume possible binding
of thrombin to fibrin as demonstrated by previous studies [24],
[21], in which high and low affinity sites were detected.
Surprisingly, our results show that the molecular mobility
decreases not only in the dense fibrin networks, but also in the
networks prepared with low (less than 1 mg/mL) fibrinogen
concentrations. Clearly, the protein binding probability should be
proportional to the exposed surface of the fibrin fibers. As we
found (Figure 3B), the fiber thickness decreases as the fibrinogen
concentration increases. Thicker fibers incorporate a larger
fraction of probe molecules than thin fibers, which affects the
total mobile fraction. Intuitively, as the fibrin volume fraction
increases with the further increase of fibrinogen concentration
(greater than 2 mg/mL), probe mobility becomes suppressed due
to the larger exposed fibrin surface area and smaller pore sizes of
the denser network. Our findings are consistent with [21], which
indicated irreversible binding of thrombin to fibrin and depen-
dence of binding affinity on fiber thickness. Thus, the presence of a
small non-mobile fraction can be attributed to probe specific
binding to fibrin fibers (thrombin) as well as probe trapping inside
fibrin nano-pore structures (thrombin, IgG).
Effect of Fibrin Cap on Hemodynamics and Protein
Transport
One of the factors determining thrombus growth is the spatial
distribution of hemostatic activators such as thrombin which
causes activation of platelets and fibrin polymerization. Based on
our observations that stabilized thrombi are covered by fibrin [2]
and using our in vitro fibrin permeation and protein diffusivity
measurements, we built a hemodynamics model to study the effect
of the fibrin network on thrombin transport. In the model
(Figure 6A), the geometry of a small thrombus comprises a central
non-permeable core of radius a consisting of densely packed
activated platelets and a permeable fibrin network covering the
thrombus core. The exterior shape of a thrombus is approximated
by a hemisphere of radius b. The porous structure of the fibrin cap
permits blood flow within the cap, and therefore the transport of
proteins includes both diffusion and advection.
To determine which mechanism drives protein transport in a
thrombus and how it depends on permeability of the network and
protein size we compared advective and diffusive fluxes within the
fibrin cap. We calculated the flow field for a small thrombus with
dimensions, b~40mm and a~20mm using solution for the stream
function (Equations (13) and (14) in Text S3). We found that the
variation of fibrin cap permeability from high to low values
noticeably changes the flow through the cap. Highly permeable
cap (k~700mm2) hardly affects the flow outside the thrombus
core (Figure 6C). As the permeability of the cap decreases down to
Figure 4. A: Confocal images of fibrin networks for different
fibrinogen concentrations (left to right): 0.5 mg/mL, 2 mg/mL,
3 mg/mL, and 4 mg/mL. Scale bar is 30 mm. B,C: Diffusivity of
different probes in fibrin gel as a function of
ffiffiffi
a
p
(B) and fibrinogen
concentration (C): circles - thrombin molecules, squares - Fab IgG
fragments, diamonds - azobenzene-labeled BSA molecules [19], left
triangles - 228 nm diameter PEG-coated particles [20], right triangles -
526 nm diameter PEG-coated particles [20], 1 - Johnson’s model [38]
Equation (3) (Text S2); 2 and 3 - thrombin and IgG fits obtained using
Equation (2). All data points refer to fibrin gels formed at 7.5 pH and
thrombin concentration of 1 NIH U/mL.
doi:10.1371/journal.pcbi.1003095.g004
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its minimum value of 3 mm2, the cap performs almost as a non-
permeable shell restricting flow within the thrombus (Figure 6B).
In the vicinity of the non-permeable thrombus core, the flow
velocity tends to zero according to no-slip boundary conditions,
which leads to the formation of a diffusion layer near the surface of
the core (Figure 7A). The thickness of this diffusion-prevailing
layer can be found from the balance between advective and
diffusive fluxes, cU(r,h)^D+c^Dc=d, where d is the thickness of
the diffusion layer, c is the protein concentration on the core
surface, D is the protein diffusivity, and U(r,h) is the local
advection velocity. In terms of the Peclet number, Pe~dU=D, this
condition means Pe=1, which yields the thickness of the diffusion
layer profile, d^D=U(r,h). Therefore, d linearly depends on the
protein diffusion coefficient and inversely proportional to the local
advection velocity U , which in turn, depends on the fibrin cap
permeability k (Equation (14) in Text S3). Our calculations
showed that in high permeable networks the thickness of the
thrombin diffusion layer was about 4% of the thrombus radius b,
whereas for low permeable networks d ranged from 10% to 20%
of b. The larger Fab IgG molecules have 2x lower diffusivity
resulting in a 2x thinner diffusion profile than thrombin. This
points out the importance of considering effects of protein size on
diffusion retardation. The presence of multiple protein molecules
inside the thrombus will result in different diffusion layer profiles
and therefore, different spatial distributions of proteins inside the
thrombus.
Thrombin Transport. To model spatial temporal evolution
of thrombin, we assumed that thrombin was generated on the
surface of platelets and was initially distributed in a 2 mm thick
spherical layer near the thrombus core. The cap thickness was
assumed to be 5 mm which was the thinnest cap observed in our
experiments. Simulations revealed that over the time interval of
38 ms high and low permeable networks limited the transport of
thrombin to various extent (Figure 8, see also Figure S2). After
38 ms thrombin appeared downstream of the high permeable
thrombus cap whereas in low permeable cap thrombin just
reached the surface of the cap, remaining inside the thrombus. In
both cases thrombin concentration was low on most of the cap
surface as the thrombin was washed downstream. These results
compliment previous experimental observations [25] of platelets
adhesion and aggregation downstream of a thrombus during its
formation. While these observations were related to purely
mechanical activation of platelets due to blood flow shear micro-
gradients, our results additionally emphasize the importance of the
spatial distribution of thrombin generated by the thrombus core.
Effect of Fibrin Cap Permeability on Thrombus
Mechanical Stability. To assess the effect of fibrin cap
permeability on the mechanical stability of a thrombus (emboli-
zation), the stress tensor was integrated over the thrombus surface
and the hydrodynamic force F acting on the thrombus was
calculated (Equation (30) in Text S3). Figure 7B shows how this
force depends on the fibrin network permeability and thickness.
The presence of a high permeable fibrin cap results in a force close
to that acting on a thrombus core. As the fibrin volume fraction in
a cap increases, F monotonically approaches the force on a non-
permeable thrombus cap. Particularly, for the thrombus with
dimensions of a~20 mm and b~40mm, a highly permeable
20 mm fibrin cap with k&103 mm2, reduces F by almost 50%.
Therefore, as the fibrin cap of the thrombus develops, enhancing
the internal cohesive forces within the thrombus, the permeability
of the cap decreases and the stress on the thrombus surface
increase. As a result, if flow induces the thrombus to embolize, it is
more likely that a thrombus with a denser fibrin network would
detach from the vein surface as a whole.
Discussion
This paper provides justification for a previously unrecognized
possible mechanism limiting growth of small asymptomatic
thrombi. The mechanism suggests that the fibrin network
overlaying a thrombus observed in mice limits the thrombus
growth by affecting the transport of proteins and by separating
resting platelets in flowing blood from regions of high thrombin
concentration generated by the thrombus core. Our analysis
integrating experiments on protein diffusion and fluid permeation
with the hemodynamic thrombus model revealed that permeabil-
ity of the fibrin network and protein diffusivity are important
factors affecting transport of blood proteins inside the thrombus.
We found that over a physiologically relevant range of
fibrinogen concentrations (0.5 to 4 mg/mL) fibrin networks do
not seem to form a strong diffusion barrier and that they minimally
restrict the diffusion of thrombin. It was shown that the diffusivity
of thrombin in the fibrin network can be hindered by 13%,
whereas diffusivity of bigger molecules, Fab IgG, can be reduced
by as much as 22%. We also found that the fibrin network
permeability, k, decreases by three orders of magnitude when
fibrinogen concentration increases from 0.5 to 4 mg/mL. This
essentially reduces advective flow in thrombi. It should be noted
that although FRAP permits measuring diffusivity of proteins in a
biopolymer network environment, some limitations exist when
studying diffusion in extracellular matrices. As was recently shown
[26], in cases where there is cellular accumulation and degradation
of the protein diffusant, if diffusion is fast enough, overall FRAP
kinetics tends to reflect the time scale of uptake and degradation
Table 1. Parameters in equation (2).
Probe Hydrodynamic diameter, SdsT, nm Solute flexibility, fs Fiber flexibility, ff s
Fab IgG 11.2 0.1 1 27
thrombin 4.1 0.1 1 17
doi:10.1371/journal.pcbi.1003095.t001
Figure 5. Mobile fraction of Fab IgG (A) and thrombin (B) in the
fibrin gel at different fibrinogen concentrations.
doi:10.1371/journal.pcbi.1003095.g005
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rather than diffusion. These effects can be important when
performing FRAP of thrombin diffusing through platelet aggre-
gates composing a thrombus core. Thrombin binding to platelets’
(GP) Ib-V-IX receptors [27] makes the fluorescence recovery a
complex function of both binding and diffusion and therefore,
requires proper quantitative interpretation [28]. In this case, one
should consider Fluorescence Correlation Spectroscopy [29] as an
alternative to the FRAP method to measure molecular diffusion
[26].
The experimentally obtained metrics characterizing diffusive
and advective transport inside the clot were incorporated into a
thrombus hemodynamical model to run predictive simulations.
We showed that the size of diffusive and advective regions strongly
depends on the permeability, k, of the fibrin cap and the diffusion
coefficient, D, of the protein. We demonstrated that the presence
of a permeable fibrin cap limits thrombin accumulation on the
thrombus surface to its downstream zone. The thrombin
concentration on the upstream thrombus surface and in the
region above the core are insufficient to support activation of
resting platelets in flowing blood near the thrombus. In a high
permeable cap, advective flow washes thrombin produced on the
surface of the platelets in the thrombus core downstream, thus
limiting continued growth except at the very downstream surface
of the thrombus. Meanwhile, a low permeable fibrin cap
impenetrable to platelets can delay platelet exposure to thrombin
and, subsequently, reduce platelet activation and aggregation.
The structural composition of thrombi can vary depending on
the vessel type (venous versus arterial), the nature of the vessel
injury, and physiological and hemodynamic conditions. Recently,
[30], [31] studied thrombus development in mouse cremaster
arterioles and did not observe fibrin accumulation on the luminal
thrombus surface that we see on stabilized small thrombi formed
in venules. There are several differences in the injury models that
might account for the reported difference in thrombus structure.
Arterial thrombi form at higher shear rates and are platelet rich,
while venous thrombi are fibrin rich. Additionally, the injury
model reported by Stalker et al [31] involves vessel rupture and
clot formation in the extravascular space while in the mesentery
model thrombi formed in the absence of detectable bleeding.
Thus, the extent of injury and exposure of blood to the internal
layers of the vessel wall is different in the two injury models. In
injuries in which we induce bleeding we observe rapid fibrin
accumulation at the base of the thrombus, similar to what was
observed in [31].
Recently, using thrombin-sensitive platelet binding sensor (ThS-
Ab), Welsh et al. [30] identified thrombin rich regions in the
Figure 6. A: Model representation of a thrombus consisting of a nonpermeable core of radius a and a fibrin cap of thickness b{a,
where b is the radius of the thrombus. Flow is uniform at infinity. B,C: Velocity field near the thrombus (a~20 mm, b~40mm) with low (B)
(k~3 mm2) and high (C) (k~700mm2) permeable fibrin cap, the flow Reynolds number, Re~rlU0b=ml~0:4. The flow at infinity is along the
horizontal axis. Color scale shows the relative absolute velocity U=U0 .
doi:10.1371/journal.pcbi.1003095.g006
Figure 7. A: Diffusion and advection layers identified in the fibrin cap for thrombin and Fab IgG. Diffusion prevails near the thrombus
surface and depends on molecular size. Smaller than Fab IgG complexes thrombin molecules have higher mobility resulting in thicker diffusion layer.
Diffusion layer profiles for thrombin and Fab IgG for low (k~3mm2) and high (k~700mm2) fibrin cap permeabilities are shown. Flow Reynolds
number Re~0:4, a~20mm, b~40mm. B: Force acting on a thrombus surface as a function of the permeability of the fibrin cap for different radii
values of the core, a, and the thrombus, b. For each permeability value, the force is non-dimensionalized by the force acting on a nonpermeable
thrombus of the same size.
doi:10.1371/journal.pcbi.1003095.g007
Protein Transport through Fibrin Networks
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developing thrombus. The sensor binds CD41 on platelets and
following thrombin cleavage of the ThS moiety generates a
fluorophore. According to this study, the highest levels of thrombin
arose between 40 and 160 seconds nearest the injury site where
fibrin colocalized and where the thrombus was most mechanically
stable. Low thrombin activity was detected away from the vessel
wall in the thrombus and was below the minimum detection limit
in the outer most, 10 micron thick, layer of the thrombus.
Although thrombus composition is different in arterioles, these
results are in agreement with our simulations for venous thrombi,
showing that thrombin concentration decreases from the throm-
bus interior to its surface, down regulating thrombus growth.
Stalker et al. [31] and Voronov et al. [32] reported the transport
of different size molecules through platelet-reach thrombi. It was
shown [31] that greater packing density in the core facilitated
contact-dependent signaling and limited entry of plasma-borne
molecules visualized with fluorophores coupled to dextran and
albumin. Using Lattice Boltzmann method to simulate the flow
through a reconstructed thrombus and Lagrangian Scalar
Tracking with Brownian motion transport to model diffusion,
transport of different factors was simulated in [32]. Modelling was
performed for an input average lumen blood velocity of 0.478 cm/
s, which resulted in 0.2 mm/s mean flow rate within the thrombus
outer shell. The shell was calculated to be 100-fold more
permeable than the thrombus core with core permeability of
10{15 m2. These results support our assumption that platelet core
in our thrombus model can be considered impermeable relative to
the fibrin cap with permeability in the range from 10{12 to
10{9 m2.
In [32] the effective diffusion coefficients of FX, ADP and Ca
were calculated and the averaged tortuosity, defined as the ratio of
the diffusion coefficient in pure liquid phase to that in the clot, was
found to be from 2 to 2.5. Meanwhile, our measurements provide
the maximum achievable tortuosity corresponding to 4 mg/mL
fibrinogen concentration to be around 1.14 for thrombin and 1.28
for Fab-IgG. Although these experimentally derived tortuosity
values and tortuosity values calculated in [32] were obtained for
different thrombus models and experimental conditions, it is likely
the platelet clots hinder molecular diffusion to a greater extent
than fibrin networks due to smaller platelet clot pore sizes. Our
findings as well as results in [32] demonstrate that both fibrin cap
and platelet-rich clots do not present a strong diffusion barrier for
the relevant molecules, whereas, permeability can greatly affect
protein transport in thrombi.
Overall, our results complement recent studies on thrombus
development and emphasize the importance of spatial distribu-
tions of sites of factor activation and factor activity in regulating
thrombogenesis. Our findings suggest that timely formation of a
fibrin network on the surface of a developing small thrombus could
limit its further growth. The proposed mechanism can prevent
small blood clots from becoming large pathological thrombi
creating life threatening emboli.
Methods
Modeling Approach
Biological background. Fibrin and platelets are the major
components of a growing thrombus. Fibrin is formed in a
thrombus when its soluble precursor protein in blood, fibrinogen,
is cleaved by the enzyme thrombin and polymerizes to form a
fibrin gel. Fibrin(ogen) mediates platelet adhesion by linking
adjacent activated platelets and forms a network providing
structural stability. Platelets are cell fragments present in blood
that bind to sites of vessel injury. Upon binding to the injury site,
platelets can be activated, resulting in dramatic shape changes and
the release of prothrombotic factors. Activated platelets support
coagulation reactions that generate thrombin to activate additional
platelets and convert fibrinogen to fibrin. These activities suggest
that the prothrombotic activity on the thrombus surface promotes
continued growth by generating fibrin and incorporating and
activating new platelets. It is not clear what processes disrupt this
positive feedback mechanism and prevent thrombi from growing
indefinitely [33–37].
Figure 8. Evolution of thrombin concentration for low (k~3 mm2) and high (k~700mm2) permeable fibrin networks in time: 0 s (A, D),
13 ms (B, E), 38 ms (C, F). ‘TC’ denotes a thrombus core. The arrow shows the direction of flow. The flow Reynolds number, Re~0:4. The color bar
shows thrombin concentration relative to its initial value when thrombin is uniformly distributed in a 2 mm thick layer near the thrombus core
(t=0 s).
doi:10.1371/journal.pcbi.1003095.g008
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Our previously developed multiscale model [4] of thrombus
formation included molecular signaling considerations (platelet
activation), biochemical reactions (the coagulation and anticoag-
ulation pathways) and blood flow (hemodynamic effects). The
model not only described how the thrombus developed in time but
also included spatial considerations. The model predicted that
platelets flowing in blood initially aggregated at the injury site,
were activated by agonists and supported coagulation reactions
that generated thrombin. Thrombin is not only a potent platelet
activator, but also catalyzes the formation of fibrin. The model
supported our experimental observations that after the formation
of an activated platelet core, a fibrin network would form on the
thrombus surface. It suggested that the fibrin cap forming on the
thrombus surface might limit its growth by interfering with the
transport of thrombin. Thus, the model integrated intracellular
signaling events, a network of biochemical reactions and
hemodynamic considerations to suggest a novel mechanism that
might limit thrombus growth.
Diffusion Model. We used the extended Ogston’s model
[22] for thick flexible fibers, which expresses protein diffusivity in a
network as follows,
D=D0~expf{
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
a=½(fsff =3)2z(2=s)2a{1
q
g, ð2Þ
where fs and ff are the solute and fiber flexibility factors (see
Table 1), s is a constant represented in a limiting step size, c,
through c{2~(s(rszrf ))
{2z(0:5
ffiffiffiffi
pl
p
){2, where l is a fiber
length per unit volume, and
a~{ln(1{w)(1zrs=rf )
2: ð3Þ
For comparison, we also used the effective medium model by
Johnson et al. 1996 [38] assuming multiplication of the retardation
due to steric (S) and hydrodynamic interactions (H) (see Text S2
for details).
Thrombus Hemodynamics Model. Although it was ob-
served [39,40] that large thrombi have very heterogenous
structure, there are no direct measurements of permeability
variations inside the thrombus. It was reported [9] that platelet
core represents a consolidated, tightly packed mass. It was also
found [9] that porosity is least at the thrombus core where
platelets have undergone spreading and are tightly bound to one
another and greatest in the outer regions of the thrombus.
Moreover, there were some in vitro experiments [3,41] studying
the structure of fibrin networks under different conditions. These
studies demonstrated small spatial variations of pore sizes within
the network generated under the same conditions. Therefore, as a
first order approximation, we assume that the permeability k of
fibrin cap is uniform and the thrombus core has a negligible
permeability.
The composite sphere approach developed in [42,43] is adopted
to model the flow around and through a thrombus. The model of a
thrombus employs a composite spherical structure with an
impermeable core (activated platelets and fibrin) and a permeable
shell (fibrin cap). Hemodynamics is modeled using Newtonian
incompressible steady axisymmetric flow with velocity U0 at
r??. For the thrombus of radius b with a core of radius a, a
creeping flow around the thrombus is described by the Stokes and
continuity equations
mDU~+p, and +:U~0,r§b, ð4Þ
where U is the velocity vector (Ur,Uw,Uh), and p is the fluid
pressure. Flow inside the fibrin cap having a uniform permeability
k is described by the Brinkman and continuity equations
{(m=k)UczmcDUc~+pc, and +:Uc~0,aƒrƒb, ð5Þ
where the superscript c refers to macroscopic quantities in the
fibrin cap region, and mc is an effective fluid viscosity in porous
medium assumed to be equal to m. The surface of the thrombus
core is assumed to be nonpermeable and no-slip boundary
conditions are imposed at r~a. On the surface of the fibrin cap
(r~b) the continuity of the velocity vector and the stress tensor are
stated and a uniform flow is imposed at r?? (see Text S3 for
details).
Transport of thrombin is modeled by the diffusion-advection
equation coupled with Equations (4) and (5)
L~c=L~tz~U+(~c)~(1=Pe)D~c, ð6Þ
where the flow velocity and thrombin concentration are non-
dimensionalized as, ~U~U=U0, ~c(~t,~r,h)~c(t,r,h)=c0. Coordinates
and time are nondimensionalized as ~r~r=a and ~t~tU0=a, where
a is the radius of the thrombus core and U0 is the flow velocity at
r??. The Peclet number is defined as Pe~aU0=D, and D is the
diffusion coefficient of thrombin determined from our experi-
ments. Equation (6) is solved numerically using minmod flux
limiter method [44] with the following boundary conditions in the
interval 0vhv2p: ~c~t,~r~1,h~1; ~c~t,~r??,h~0, and the initial distri-
bution of thrombin in the form of a spherical layer near the
thrombus core: ~c0~~c~t~0~1,avrƒazdz; ~c~t~0~0,rwazdz,
where dz is the thickness of the initial thrombin layer.
It should be noted that the use of Stokes and Brinkman-Darcy
equations is valid if the local Reynolds number is less than 1. At
higher Reynolds numbers inertial effects can be significant and the
relation between liquid flow rate and pressure gradient is no longer
linear. However, the local Reynolds number can be small even if
the Reynolds number calculated with respect to the blood vessel
diameter is large. Assuming a parabolic flow velocity profile in a
blood vessel of radius R and a small thrombus (b=R%1), it is
straight-forward to show that the criterion, Re~u(r{b)b=nv1,
where u(r{b) is the velocity of the flow in the vicinity of the
thrombus and n is the blood viscosity, yields
bƒ0:5
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
pR3n=Q
p
~0:5
ffiffiffiffiffiffiffiffiffiffiffiffi
nR=u0
p
. Here, Q~pR2u0, is the volu-
metric flow rate through the vessel, u0~1=(pR
2)
ÐR
0
2pru(r)dr is
the axial averaged blood flow velocity, and n is the blood viscosity.
Assuming a vessel radius of 200 mm, an average velocity of 1 cm/
s, and a blood viscosity of*3:10{6 m2=s, the model limitation on
the thrombus size is bƒb0~122mm. In experiments, the observed
thrombi were smaller than 60 mmƒb0, and therefore the use of
Equations (4) and (5) is justified.
Materials and Methods
Fibrin gel formation. Fibrinogen (Enzyme Research Labo-
ratory, South Bend, IN) was aliquoted in 30 mL at 20 mg/mL and
stored at280uC for later use. Desiccated labeled fibrinogen (5 mg)
(Life Technologies, Grand Island, NY) was dissolved in 20 mM
sodium citrate at pH 7.4. The preparation was frozen at280uC in
5 mL aliquots at 4 mg/mL. Human a-thrombin (Enzyme
Research Laboratory, South Bend, IN) was dissolved in 50 mM
sodium citrate, 0.2 M NaCl, 0.1% PEG-8000 at pH 6.5 and
stored at 280uC as 3 mL aliquots at 1 U=mL. Aliquots were
thawed only once at 37uC before each experiment. Labeled
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thrombin was generated by incubating fluorescein labeled
thrombin inhibitor FPR-chloromethylketone (PPACK) (Hemato-
logic Technologies, Essex Junction, VT) with a-thrombin (Enzyme
Research Labs, South Bend, IN) in PBS buffer. Labeled thrombin
was purified from unbound fluorescein-PPACK by gel filtration,
aliquoted and stored at 220uC. The labeled Fab fragment
(AlexaFlour 488 goat anti mouse IgG Fab, 2 mg/mL) was
purchased from Life Technologies (Grand Island, NY). Gels were
prepared by first, mixing fibrinogen, labeled fibrinogen, and probe
molecules with buffer in a tube. The ratio of unlabeled to labeled
fibrinogen was 1:20 and the final fibrinogen concentration ranged
from 0.2 to 4.2 mg/mL. The Fab Igg concentration was 0.02 mg/
mL and labeled thrombin concentration was 0.01 mg/mL.
Polymerization was initiated by adding thrombin (1 U/mL final),
the solution was rapidly pipeted 7–8 times and injected into glass
microchannels (VitroCom, NJ) of rectangular cross sections
(200 mm62 mm, 3 cm long, wall thickness 20 mm). Microchan-
nels were placed on a wet paper tissue inside a sealed petri dishes
and gels were incubated for 3 hours for a complete fibrinogen
polymerization. For FRAP, the ends of the channels were then
sealed with silicon grease to prevent evaporation and eliminate any
internal flow.
The volume fraction of fibrin, w, in the prepared gels was
determined as
w~j
mf nf
mf nfz(mwzmb)nl
, ð7Þ
where mf , mw, and mb are masses of desiccated fibrinogen, water,
and buffer and nf , nl are the specific volumes of fibrinogen
(0.725 cm3=g), and water-buffer solution (1.02 cm3=g), respec-
tively. Masses mfzmb and mw were determined from weighing of
hydrated and dehydrated gel and mb was known from the
preparation protocol, j*5 is a factor accounting for the difference
between fibrin and fibrinogen densities [23,45].
Clot permeability measurements. To measure permeabil-
ity, clots were prepared in transparent plastic tubes and glass
capillaries having internal diameter of 1.5 mm and 1 mm,
respectively. The length of plastic tubes was 2 cm and the length
of glass capillaries varied from 1 cm to 1.9 cm. Distilled water was
perfused hydrostatically by gravity through the tube. The flow rate
was determined by measuring the mass of outflow liquid with
scales (Acculab, ALC-320.3, d =0.001 g) at different times for
three different pressure drops. The pressure drop across the gel
was measured using a pressure transducer as well as by liquid
column height measurements. Permeability was determined from
Darcy’s equation as k~LmQ=(SDP), where L is the length of the
cylindrical clot, m is liquid viscosity, and DP is the pressure drop
across the clot.
Protein size measurements. Dynamic light scattering
(DLS) was used to measure thrombin and Fab IgG hydrodynamic
diameters. In DLS, Brownian motion is measured and related to
the size of the particles through the Stokes-Einstein equation
d~kBT=(3pmD), where kB is the Boltzmann’s constant, T is the
temperature, m is the dynamic viscosity, and D is the diffusion
coefficient. Since most molecules are not spherical, the hydrody-
namic diameter is determined as the diameter of a sphere that has
the same translational diffusion speed as the molecule. Measure-
ments were performed at 30uC in three series of 15 measurements
for each sample of thrombin and Fab IgG solutions. Zetasizer
Nano S90 with Zetasizer software was used for DLS data
collection and analysis.
Microscope equipment. FRAP measurements and fibrin
network imaging were performed using laser confocal microscope
Zeiss LSM 510 Meta with 206, 636, and 1006 objectives (20/
0.4, 63x/1.4 Oil DICIII, and 100x/1.4 Oil DICIII). The sample
ROI was bleached using 720 nm laser line (Multiphoton Coherent
Chameleon XR tunable pulsed laser, 705–980 nm, maximum
power 1 W). The bleaching was performed in circular ROIs at
typical laser output power of 25–50 mW. For monitoring a
recovery signal from labeled thrombin and Fab Igg, the sample
was illuminated using the 514 nm laser line from an Argon-ion
laser. The emitted fluorescence was detected after passing through
544–608 nm band pass filter. For acquisition of fibrin network
images, the pinhole size was adjusted to 1 Airy unit and a 561 nm
laser line (DPSS561-10) with 544–608 nm band pass filter were
used. The output laser power during image acquisition ranged
from 0.1 to 0.15 mW. Details of FRAP method are provided in
Text S1.
Supporting Information
Figure S1 Force on a thrombus as a function of non-
dimensional fibrin cap thickness D=a~b=a{1 for differ-
ent values of the parameter a~a=
ffiffiffi
k
p
. A: k~3mm2, B:
k~700 mm2.
(TIF)
Figure S2 Simulation results of thrombin distribution
for (a) low (k~3 mm2) and (b) high (k~700mm2) perme-
able fibrin networks after 75 ms of being exposed to
external flow, Re~0:4. ‘TC’ and ‘FC’ denote a thrombus
core and a fibrin cap.
(TIF)
Text S1 FRAP method.
(PDF)
Text S2 Diffusion model.
(PDF)
Text S3 Thrombus hemodynamics model.
(PDF)
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